样式: 排序: IF: - GO 导出 标记为已读
-
Issue Information Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-08
Click on the article title to read more.
-
ProGlide‐AngioSeal versus ProGlide‐FemoSeal for vascular access hemostasis posttranscatheter aortic valve implantation Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-08 Mohamed Samy, Martin Landt, Nader Mankerious, Arief Kurniadi, Sultan Alotaibi, Ralph Toelg, Mohamed Abdel‐Wahab, Holger Nef, Abdelhakim Allali, Gert Richardt, Karim Elbasha
BackgroundThe hybrid strategy combining plug‐based and suture‐based vascular closure devices (VCD) was introduced as a promising technique for vascular access hemostasis after transcatheter aortic valve implantation (TAVI) with satisfactory outcomes. However, data comparing two plug‐based VCDs each in the combination with a suture‐based VCD, namely ProGlide/AngioSeal (P/AS) with ProGlide/FemoSeal (P/FS)
-
Coagulation after transcatheter aortic valve replacement: Still a black box? Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-08 N. Patrick Mayr, Yousuke Taniguchi
Key points Post‐TAVR, there is a significant increase in pro‐coagulatory parameters in conjunction with a decrease in platelet counts. Finding the right balance between thrombosis and bleeding after the procedure is essential, and the results presented here will add knowledge to this topic The effect of protamine in different dosages on the postoperative course of thrombin generation and coagulation
-
Chronic total occlusion percutaneous coronary intervention of anomalous coronary arteries: insights from the PROGRESS CTO registry Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-04 Gustavo M. Hirata, Athanasios Rempakos, A. Walker Boyd, Michaella Alexandrou, Deniz Mutlu, James W. Choi, Paul Poommipanit, Jaikirshan J. Khatri, Laura Young, Rhian Davies, Sevket Gorgulu, Farouc A. Jaffer, Raj Chandwaney, Brian Jefferson, Basem Elbarouni, Lorenzo Azzalini, Kathleen E. Kearney, Khaldoon Alaswad, Mir B. Basir, Oleg Krestyaninov, Dmitrii Khelimskii, Nazif Aygul, Nidal Abi‐Rafeh, Ahmed
BackgroundThere is limited information about the frequency and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in anomalous coronary arteries (ACA).MethodsWe examined the clinical and angiographic characteristics and procedural outcomes of CTO PCI in ACA among 14,173 patients who underwent 14,470 CTO PCIs at 46 US and non‐US centers between 2012 and 2023.ResultsOf
-
Safety, efficacy, and optical coherence tomography insights into intravascular lithotripsy for the modification of noneruptive calcified nodules Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-04 Okasha Tahir, Syed Ibad Ali, Fatima Zehra, Laiba Shamim, Muhammad Umar
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
One‐month DAPT after biodegradable‐polymer everolimus‐eluting stent implantation in women at high‐bleeding risk: Insights from the POEM trial Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-03 Matteo Maurina, Carlo Andrea Pivato, Vijay Kunadian, Luca Testa, Carlo Briguori, Andrea Pacchioni, Alessia Chiara Latini, Nicola Cesani, Raffale Piccolo, Carmine Musto, Gennaro Sardella, Ciro Indolfi, Damiano Regazzoli, Valeria Paradies, Giulio Stefanini
AimsWe conducted a prespecified subanalysis of the POEM trial to assess the association between sex and clinical outcomes following a short 1‐month dual‐antiplatelet‐therapy (DAPT) period after percutaneous coronary intervention (PCI) with bioresorbable polymer everolimus‐eluting stent (BP‐EES) among patients at high bleeding risk (HBR).BackgroundShortening the DAPT period after PCI is an effective
-
Use of sirolimus‐coated balloon in de novo coronary lesions; long‐term clinical outcomes from a multi‐center real‐world population Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-03 Sandeep Basavarajaiah, Vinoda Sharma, Alessandro Sticchi, Gianluca Caiazzo, Filiberto Fausto Mottola, Bhagya Harindi Loku Waduge, Sampath Athukorala, Mazaya Fawazy, Luca Testa, Antonio Colombo
BackgroundSirolimus‐coated balloon (SCB), a relatively novel technology appears attractive due to the drug properties (safety and efficacy) and sirolimus remains the drug of choice in stents. However, there is limited data long‐term data on SCB. In this study, we have explored the clinical outcomes following the use of SCB in de‐novo lesions from a real‐world practice.AimsTo report long‐term clinical
-
A new simple technique for stabilizing the guidewire position within the left ventricle during transcatheter mitral valve‐in‐valve implantation Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-02 Kothandam Sivakumar, Pramod Sagar, Puthiyedath Thejaswi, Sreeja Pavithran
Transcatheter mitral valve‐in‐valve implantation is a preferred treatment for degenerating mitral bioprosthetic valves in high‐risk surgical patients. A balloon‐expandable transcatheter heart valve delivered through a postero‐inferior transseptal puncture is deployed within the prosthesis over a guidewire secured in the left ventricle. Patients with aneurysmal left atrium and altered angulation between
-
Challenges in the diagnosis and management of dry tamponade Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-02 Jasleen Tiwana, Kathleen E. Kearney, William L. Lombardi, Lorenzo Azzalini
Dry tamponade is a rare complication of percutaneous coronary intervention. It encompasses a heterogenous pathophysiology and is used to describe hemodynamic compromise secondary to a coronary artery perforation, without free‐flowing fluid in the pericardium. Tamponade physiology can result from compressive epicardial, intramyocardial, subepicardial hematomas, or dissecting intramyocardial hematomas
-
Carina: A major determinant in the pathophysiology and treatment of coronary bifurcation lesions Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-02 Marco Zuin, Claudio Chiastra, Umberto Morbiducci, Diego Gallo, Claudio Bilato, Gianluca Rigatelli
Over the last decade, several in vivo and computational investigations have significantly advanced our understanding of the pathophysiology of coronary bifurcations, contributing to the enhancement of their percutaneous revascularization. The carina of the coronary bifurcations plays a substantial role in generating their main hemodynamic features, including distinctive flow patterns with secondary
-
Atrial fibrillation versus non‐atrial fibrillation coronary embolism Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-01 Alberto Vera, Arturo Lanaspa, Octavio Jiménez, Adela Navarro, María Teresa Basurte, Maite Beunza, Mercedes Ciriza, Nuria Basterra, Rafael Sadaba, Valeriano Ruiz‐Quevedo, Virginia Álvarez
BackgroundCoronary embolism (CE) is an uncommon cause of non‐atherosclerotic acute myocardial infarction (AMI). Although atrial fibrillation (AF) is the main cause of CE, evidence of clinical, biochemical, echocardiographic, angiographic findings and outcomes of AF CE is lacking.MethodsWe retrospectively analyzed 85 consecutive patients with CE that was diagnosed based on criteria encompassing clinical
-
Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-10-01 Takashi Yanagiuchi, Kuniyoshi Fukai, Koji Sogabe, Yoshihiro Iwasaki, Keita Hirano, Taku Kato, Hirokazu Yokoi, Kan Zen, Satoaki Matoba
BackgroundDespite the widespread use of drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions, there is still no consensus on treatment strategies for DCB restenosis. This study aimed to determine the risk factors for recurrent restenosis after repeat DCB therapy for DCB restenosis in FP lesions.MethodsThis multicenter retrospective study assessed 1176 consecutive limbs in 860 patients who successfully
-
Sex differences in transradial access failure in ST segment elevation myocardial infarction Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-30 Biljana Zafirovska, Aleksandar Jovkovski, Ivan Vasilev, Hajber Taravari, Darko Kitanoski, Danica Petkoska, Jorgo Kostov, Kalon K. L. Ho, Sasko Kedev
BackgroundTransradial access (TRA) is now the default access site for PPCI, but technically is a more challenging approach mostly due to anatomic challenges connected to the RA.AimsTo assess the differences according to sex in radial artery (RA) access site characteristics during primary percutaneous coronary intervention (PPCI) for ST segment elevation myocardial infarction (STEMI).Material and MethodsAll
-
Validation of virtual fractional flow reserve pullback curves Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-29 Ruiko Seki, Damien Collison, Kazumasa Ikeda, Jeroen Sonck, Daniel Munhoz, Dario Tino Bertolone, Brian Ko, Michael Maeng, Hiromasa Otake, Bon‐Kon Koo, Tatyana Storozhenko, Frederic Bouisset, Marta Belmonte, Attilio Leone, Monika Shumkova, Tom J. Ford, Thabo Mahendiran, Colin Berry, Bernard De Bruyne, Keith Oldroyd, Koshiro Sakai, Takuya Mizukami, Carlos Collet
BackgroundAngiography‐derived fractional flow reserve (virtual FFR) has shown excellent diagnostic performance compared with wire‐based FFR. However, virtual FFR pullback curves have not been validated yet.ObjectivesTo validate the accuracy of virtual FFR pullback curves compared to wire‐based FFR pullbacks and to assess their clinical utility using patient‐reported outcomes.MethodsPooled analysis
-
Elevated myocardial extracellular volume fraction as a new predictor of conduction defects after transcatheter aortic valve replacement Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-29 Mehmet Cilingiroglu, Ibrahim Halil Inanc
Key points Transcatheter aortic valve replacement (TAVR) is now the standard of care for patients with severe symptomatic aortic stenosis (AS). New conduction defects remain a challenge following TAVR in patients requiring permanent pacemaker implantation (PPI). CMRI identified myocardial fibrosis (MF) with an increased extracellular volume (ECV) is a new predictor for these conduction defects following
-
Impact of residual mitral regurgitation after transcatheter edge-to-edge repair in atrial functional mitral regurgitation: Results from MITRA-PRO registry Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-26 Dennis Rottländer, Jörg Hausleiter, Thomas Schmitz, Alexander Bufe, Melchior Seyfarth, Ralph Stephan von Bardeleben, Harald Beucher, Taoufik Ouarrak, Steffen Schneider, Peter Boekstegers
Transcatheter edge-to-edge repair (TEER) has emerged to address symptomatic atrial functional mitral regurgitation (aFMR) in patients who are at high operative risk.
-
HydroDynamic contrast Recanalization (HDR): Description of a new crossing technique for coronary chronic total occlusions Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-27 Mauro Carlino, Angelo Nascimbene, Emmanouil S. Brilakis, Akshitha Yarrabothula, Antonio Colombo, Sunao Nakamura, Lorenzo Azzalini, Bashir Hanif, Bilal Iqbal, Salman A. Arain
BackgroundIntraplaque delivery of contrast has been utilized during percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) to delineate anatomy and to facilitate wire crossing. Its utility as a tool to accomplish primary crossing of CTOs has not been described or validated.AimsWe describe a new technique leveraging the diagnostic and therapeutic roles of intraplaque contrast injection
-
Early outcomes with a fully retrievable SinoCrown transcatheter heart valve in patients with severe aortic stenosis Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-26 Yuehuan Li, Zhongyu Xiong, Ruobing Lei, Jiangang Wang, Haibo Zhang
BackgroundThis study summarizes and analyzes data from patients suffering from symptomatic aortic stenosis who successfully underwent transcatheter aortic valve implantation (TAVI) using a novel, completely retrievable transcatheter heart valve.MethodsWe included patients who underwent a TAVI procedure with SinoCrown valves at our center between December 2021 and September 2022. We collected 1‐year
-
The “Cuttering (Cutting‐Dottering Balloon) Technique” for treatment of flow‐limiting coronary intramural hematoma Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-26 Gabriele Luigi Gasparini, Matteo Maurina, Damiano Regazzoli, Paolo Canova, Pier Pasquale Leone, Antonio Mangieri, Bernhard Reimers
BackgroundCoronary artery dissections are caused by a tear in the vessel endothelium, resulting in blood extravasation into the subintimal space, with subsequent intramural hematoma (IMH). One potential technique to deal with this complication is the use of cutting balloons, however, a significant number of cases experienced distal propagation of the hematoma. We describe a novel technique that enhances
-
Procedural and clinical impact of intracoronary lithotripsy in heavily calcified aorto‐ostial coronary lesions Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-24 Federico Oliveri, Maura Meijer, Martijn J. H. Van Oort, Ibtihal Al Amri, Brian O. Bingen, Bimmer E. Claessen, Aukelien C. Dimitriu‐Leen, Joelle Kefer, Hany Girgis, Tessel Vossenberg, Frank Van der Kley, J. Wouter Jukema, Jose M. Montero‐Cabezas
BackgroundPercutaneous coronary intervention of calcified aorto‐ostial lesions (AOL) pose unique challenges due to anatomical propensity for recoil, leading to poorer outcomes compared to non‐AOL. Although intravascular lithotripsy (IVL) has shown excellent success and safety in heavily calcified plaques, evidence specific to AOL is limited. This study aims to evaluate the efficacy and safety of IVL
-
Optical coherence tomography characterization of degradation kinetics between second‐ and third‐generation resorbable magnesium scaffold Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-24 Masaru Seguchi, Philine Baumann‐Zumstein, Armin Fubel, Martin Pritsch, Alp Aytekin, Philipp Nicol, Jonas Altevogt, Michael Joner
AimsThis preclinical study aimed to establish optical coherence tomography (OCT)‐derived parameters that could be used in the clinical setting for assessing strut degradation in the third‐generation drug‐eluting resorbable magnesium scaffold (DREAMS‐3G), and characterize the comparative degradation profile against its precursor device (MagmarisTM scaffold).Methods and ResultsTwelve DREAMS‐3G and 10
-
Rationale and design of the randomized COmparison of Methods for Pulmonary blood flow Augmentation: Shunt versus Stent (COMPASS) trial: A Pediatric Heart Network study Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-23 Christopher J. Petit, Jennifer C. Romano, Jeffrey D. Zampi, Sara K. Pasquali, Courtney E. McCracken, Nikhil K. Chanani, Andrea S. Les, Kristin M. Burns, Allison Crosby-Thompson, Mario Stylianou, Bernet Kato, Andrew C. Glatz
Neonates with congenital heart disease (CHD) and ductal-dependent pulmonary blood flow (DD-PBF) require early intervention. Historically, this intervention was most often a surgical systemic-to-pulmonary shunt (SPS; e.g., Blalock–Thomas–Taussig shunt). However, over the past two decades an alternative to SPS has emerged in the form of transcatheter ductal artery stenting (DAS). While many reports have
-
Impact of multiple ballooning on coronary lesions as assessed by optical coherence tomography and intravascular ultrasound Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-23 Yusuke Kanzaki, Yasushi Ueki, Daisuke Sunohara, Yoshiteru Okina, Hidetomo Nomi, Keisuke Machida, Daisuke Kashiwagi, Hidetsugu Yoda, Shusaku Maruyama, Ayumu Nagae, Tamon Kato, Tatsuya Saigusa, Jouke Dijkstra, Soichiro Ebisawa, Koichiro Kuwahara
BackgroundOptimal lesion preparation for coronary lesions has been reappraised in the interventional community, given the increasing use of drug‐coated balloons for de novo lesions; however, whether multiple ballooning could achieve more favorable angiographic results compared with single ballooning remains unknown. We aimed to investigate the incremental effect of multiple ballooning on de novo coronary
-
Contrast-enhanced excimer laser coronary atherectomy Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-22 Abhishek Chaturvedi, Brian C. Case, Hayder D. Hashim, Itsik Ben-Dor, Ron Waksman, Robert A. Gallino, Nelson L. Bernardo
Click on the article title to read more.
-
Combined strategy of device‐based contrast minimization and urine flow rate‐guided hydration to prevent acute kidney injury in high‐risk patients undergoing coronary interventional procedures Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-20 Luca Paolucci, Francesca De Micco, Mario Scarpelli, Amelia Focaccio, Valeria Cavaliere, Carlo Briguori
Background and AimsContrast‐associated acute kidney injury (CA‐AKI) is a major complication following coronary procedures. We aimed to evaluate the effectiveness of a combination of urine flow rate‐(UFR) guided hydration (RenalGuardTM) and device‐based contrast media (CM) reduction (DyeVertTM) in CA‐AKI prevention.MethodsStable high‐risk patients undergoing coronary procedures with the use of DyeVertTM
-
Iatrogenic atrial septal defects in structural heart interventions: Opening the Pandora's box Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-20 Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantinos Karampinos, Christina Panagiotis Malainou, Eirini Beneki, Alexandros Koulouriotis, Daphne Pitsiori, Konstantinos Aznaouridis, Konstantina Aggeli, Konstantinos Tsioufis
In the modern era of structural heart interventions, the total number of transseptal procedures is growing exponentially, thus increasing the rate and need for management of iatrogenic atrial septal defects (iASDs). To date, there are no official guidelines on the assessment and management of iASDs, due to inconclusive evidence on whether patients benefit more from the percutaneous closure of iASD
-
Methods for treating coronary eruptive calcified nodules Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-19 Takashi Ashikaga, Tetsumin Lee, Ryoichi Miyazaki, Masashi Nagase, Toru Misawa, Masakazu Kaneko, Toshihiro Nozato
Eruptive calcified nodules (CNs) are a manifestation of severely calcified plaques, which exist in acute coronary syndrome (ACS), non‐ACS lesions. Optical coherence tomography is crucial for diagnosing and treating eruptive CNs in clinical practice. Management of eruptive CNs is still a challenge for interventional cardiologists. There have been significant advances in the treatment of eruptive CNs
-
Percutaneous closure of coronary fistulas in adults using microvascular plugs Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-19 Leire Unzué, Samantha Wasniewski, Eulogio García, Rodrigo Teijeiro‐Mestre
Percutaneous closure of coronary fistulas can be a challenge, given the tortuosity and the small caliber of the anomalous vessel. The microvascular plugs (MVP) are polytetrafluoroethylene‐coated nitinol devices designed to perform embolization of small peripheral vessels. Its reduced profile allows the release of the device through microcatheters, facilitating the intervention. We present three cases
-
Impact of systolic dominant pulmonary venous flow morphology on outcomes after mitral transcatheter edge‐to‐edge repair Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-19 Sahar Samimi, Taha Hatab, Rody Bou Chaaya, Chloe Kharsa, Fatima Qamar, Nadeen Faza, Stephen H. Little, Marvin D. Atkins, Michael J. Reardon, Neal S. Kleiman, Sherif F. Nagueh, William A. Zoghbi, Syed Zaid, Sachin S. Goel
BackgroundThe prognostic significance of intraprocedural pulsed‐wave Doppler analysis of pulmonary venous flow (PVF) during mitral transcatheter edge‐to‐edge repair (TEER) remains understudied. We aimed to investigate the prognostic value of systolic dominant‐PVF (SD‐PVF) morphology post‐TEER.MethodsIn a retrospective analysis from December 2019 to December 2022, patients undergoing mitral TEER were
-
Comparative long‐term efficacy and safety of two paclitaxel‐coated balloons with different coating strategies for the treatment of drug‐eluting coronary stent restenosis Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-18 Tobias Koch, Tobias Lenz, Tobias Rheude, Salvatore Cassese, Erion Xhepa, Michael Joner, Julinda Mehilli, Heribert Schunkert, Adnan Kastrati, Sebastian Kufner
BackgroundWe previously showed non‐inferiority of a low‐dose paclitaxel‐coated balloon (PCB) with citrate excipient (Agent PCB) as compared to normal‐dose iopromide excipient (SeQuent Please PCB) in terms of angiographic and clinical endpoints at 12 months. The long‐term clinical efficacy and safety of Agent PCB is not defined.Methods262 patients (323 DES‐ISR lesions) were enrolled in this study and
-
Outcomes of transcatheter closure for coronary artery fistulas with or without aneurysm: A comparative study Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-18 Peijian Wei, Zuo Pu, Jeffrey S. K. Chan, Yihang Li, Liang Xu, Junyi Wan, Fengwen Zhang, Gary Tse, Shouzheng Wang, Wenbin Ouyang, Gejun Zhang, Fang Fang, Xiangbin Pan
BackgroundCoronary Artery Fistulas (CAFs) Patients with aneurysm may face severe complications, necessitating prompt treatment. However, data on the outcomes of transcatheter closure in CAFs patients with aneurysm are notably scarce.MethodsThis retrospective study included all consecutive CAFs patients who underwent transcatheter closure at Fuwai Hospital from January 2010 to December 2023. Patients
-
The role of intra-vascular imaging in patients undergoing intravascular lithotripsy: Insights from the COIL registry Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-15 Bilal Bawamia, Michał Kuzemczak, Janusz Lipiecki, Jacek Legutko, Johan Bennett, Joseph Dens, Mohammad Alkhalil
The role of intra-coronary imaging in patients with stent failure undergoing intravascular lithotripsy (IVL) is unclear. We aimed to assess clinical outcomes in patients undergoing IVL treatment for stent failure stratified according to the use of intra-coronary imaging and lesion complexity.
-
Efficacy and safety of the VASCADE® MVP venous vascular closure device in patients undergoing percutaneous left atrial appendage occlusion with WATCHMAN Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-15 Hafez Golzarian, Katherine T. Graebel, Rachel Bailey, Michael B. Widmer, Arielle Thiel, Gerri Hempfling, Michael Otto, Todd Otto, Sandeep M. Patel
The VASCADE MVP venous vascular closure system is commonly used for percutaneous venotomy closure in catheter-based procedures utilizing sheath sizes 6-12 French. However, its application with larger sheaths such as ones required in left atrial appendage occlusion (LAAO) has yet to be explored.
-
Selective embolization with autologous fat to treat massive bleeding secondary to percutaneous renal biopsy Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-15 Fabio Solis-Jiménez, Alexandra Perez-Zamorano, Guering Eid-Lidt, Gian Manuel Jimenez-Rodriguez
Bleeding following a percutaneous renal biopsy is a complication that can be life-threatening. Embolization of the bleeding artery is a procedure that can limit the damage; however, embolization devices can be costly or not immediately available. This is why we present the case of a 25-year-old man with a history of multiple thromboses who underwent a renal biopsy due to suspected systemic lupus erythematosus
-
Age-related structural remodelling of the coronary circulation Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-15 Daniel Faria, Marco Lombardi, Nina van der Hoeven, Alejandro Travieso, Julius C. Heemelaar, Sukhjinder S. Nijjer, Hernán Mejía-Rentería, Guus A. de Waard, Sayan Sen, Tim P. van de Hoef, Ricardo Petraco, Mauro Echavarría-Pinto, Jan J. Piek, Justin E. Davies, Niels van Royen, Javier Escaned
While it is broadly accepted that ageing is associated with impairment of coronary microvascular function, little is known about the underlying mechanisms.
-
The effect of hydrostatic pressure on invasive coronary pressure measurements: Comparison with [15O]H2O‐positron emission tomography flow data Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-11 Adriaan Wilgenhof, Ruurt A. Jukema, Roel S. Driessen, Ibrahim Danad, Pieter G. Raijmakers, Niels van Royen, Lokien X. van Nunen, Carlos Collet, Guus A. de Waard, Paul Knaapen
BackgroundFractional flow reserve (FFR) has emerged as the invasive gold standard for assessing vessel‐specific ischemia. However, FFR measurements are influenced by the hydrostatic effect, which might adversely impact the assessment of ischemia.AimsThis study aimed to investigate the impact of hydrostatic pressure on FFR measurements by correcting for the height and comparing FFR with [15O]H2O positron
-
The impact of stroke and bleeding on mortality and quality of life during the first year after TAVI: A POPular TAVI subanalysis Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-11 Puck J. A. van Nuland, Dirk Jan van Ginkel, Daniel C. Overduin, Willem L. Bor, Jorn Brouwer, Vincent J. Nijenhuis, Joyce Peper, Arnoud W. J. van't Hof, Pieter A. Vriesendorp, Jurriën M. ten Berg
BackgroundBleeding and stroke are frequent complications after transcatheter aortic valve implantation (TAVI). The mortality risk associated with these events has been reported before, but data regarding their impact on health‐related quality of life (QoL) is limited.AimTo evaluate the impact of bleeding and stroke occurring within 30 days after TAVI, on mortality and QoL during the first year after
-
Impact of commissural alignment on the hemodynamic performance of supra‐annular self‐expandable transcatheter aortic valves Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-10 Ignacio J. Amat‐Santos, Javier Gómez‐Herrero, Pablo Pinon, Luis Nombela‐Franco, Raúl Moreno, Antonio J. Munoz‐García, Alfredo Redondo, Antonio Gómez‐Menchero, Itziar Gómez‐Salvador, J. Alberto San Román
BackgroundHemodynamic impact of commissural alignment (CA) with self‐expandable transcatheter aortic valves (TAVR) has not been investigated yet.AimsTo determine hemodynamic impact of CA with self‐expandable TAVR.MethodsMulticentric ambispective study comparing patients who underwent self‐expandable TAVR in seven centers with the Evolut Pro/Pro+ (EP) (Medtronic) and Acurate neo2 (AN2) (Boston Scientific)
-
Issue Information Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-09
Click on the article title to read more.
-
Transcatheter aortic valve implantation for severe aortic regurgitation using the J‐Valve system: A midterm follow‐up study Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-09 Min Jin, Haitao Zhang, Qing Zhou, Shuchun Li, Dongjin Wang
BackgroundTranscatheter aortic valve implantation (TAVI) is a well‐established intervention for severe aortic valve stenosis. However, its application for severe aortic regurgitation (AR) is still under evaluation. This study aims to present the 3‐year follow‐up outcomes of the J‐Valve system in managing severe AR.AimsThe aim of this study was to evaluate the mid‐term efficacy and durability of the
-
Clinical outcomes and coronary artery lesion characteristics of young patients with ST elevation myocardial infarction and no standard modifiable risk factors Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-09 Nick S. R. Lan, HuiJun Chih, Angela L. Brennan, Girish Dwivedi, Gemma A. Figtree, Diem Dinh, Dion Stub, Christopher M. Reid, Abdul Rahman Ihdayhid
Among ST-elevation myocardial infarction (STEMI) patients, those with no standard modifiable risk factors (SMuRFs: hypertension, diabetes mellitus, hypercholesterolemia, and smoking) have higher 30-day mortality than those with SMuRFs. Differences in coronary lesion characteristics remain unclear.
-
Pericardial tamponade in coronary interventions: Morbidity and mortality Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-09 Saurabh Deshpande, Hiroyuki Sawatari, Kapil Rangan, Anusha Buchade, Raheel Ahmed, Kamleshun Ramphul, Mushood Ahmed, Mohammed Y. Khanji, Virend K. Somers, Farhan Shahid, Anwar A. Chahal, Deepak Padmanabhan
Cardiac tamponade or pericardial tamponade (PT) can be a complication following invasive cardiac procedures.
-
Circumflex distortion following mitral valve repair Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-05 Hugo Pilichowski, Radu Spînu, Sébastien Gerelli, Lionel Mangin, Marc Bonnet
Mitral valve repair or replacement poses a potential risk of injury to the left circumflex coronary artery (LCx). Such injuries can arise from either direct LCx injury caused by encircling or transfixing stitches, or indirect occlusion resulting from the distortion of adjacent tissues. We provide and illustrate a representative image depicting LCx distortion. Additionally, we offer guidance to aid
-
In-hospital outcomes of ad hoc versus planned PCI for unprotected left-main disease: An analysis of 8574 cases from British Cardiovascular Intervention Society database 2006–2018 Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-05 Tim Kinnaird, Sean Gallagher, Vasim Farooq, Majd B. Protty, Hannah Cranch, Peader Devlin, Andrew Sharp, Nick Curzen, Peter Ludman, David Hildick-Smith, Tom Johnson, Mamas A. Mamas
Although data suggests ad hoc percutaneous coronary intervention (PCI) results in similar patient outcomes compared to planned PCI in nonselected patients, data for ad hoc unprotected left main stem PCI (uLMS-PCI) are lacking.
-
Differences between sexes in STEMI treatment and outcomes with contemporary primary PCI Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-04 Michael L. Savage, Karen Hay, William Vollbon, Dale J. Murdoch, Christopher Hammett, James Crowhurst, Karl Poon, Rohan Poulter, Darren L. Walters, Russell Denman, Isuru Ranasinghe, Owen Christopher Raffel
BackgroundHistorically, differences in timely reperfusion and outcomes have been described in females who suffer ST‐segment elevation myocardial infarction (STEMI). However, there have been improvements in the treatment of STEMI patients with contemporary Percutaneous Coronary Intervention (PCI) strategies.MethodsComparisons between sexes were performed on STEMI patients treated with primary PCI over
-
Sex-based differences in candidacy for transcatheter tricuspid valve intervention Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-03 Allison O. Dumitriu Carcoana, Christopher B. Scoma, Sebastian N. Maletz, Jose A. Malavet, Charissa A. Bloom, Daniela R. Crousillat, Fadi A. Matar
Women have a higher prevalence of tricuspid regurgitation (TR) and present at more advanced stages as compared with men. Given the high operative mortality associated with tricuspid valve (TV) surgery, transcatheter tricuspid valve interventions (TTVI) have emerged as a promising treatment option. We explored sex-based differences among patients with significant TR who would be expected to be eligible
-
Safety, efficacy, and optical coherence tomography insights into intravascular lithotripsy for the modification of non-eruptive calcified nodules: A prospective observational study Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-03 Ankush Gupta, Abhinav Shrivastava, Sanya Chhikara, Pruthvi C. Revaiah, Mamas A. Mamas, Rajesh Vijayvergiya, Ashok Seth, Balwinder Singh, Nitin Bajaj, Navreet Singh, Jaskarn Singh Dugal, Nalin K. Mahesh
Non-eruptive calcium nodules (CNs) are commonly seen in heavily calcified coronary artery disease. They are the most difficult subset for modification, and may result in stent damage, malapposition and under-expansion. There are only limited options available for non-eruptive CN modification. Intravascular lithotripsy (IVL) is being explored as a potentially safe and effective modality in these lesions
-
First‐in‐human: Leaflet laceration with balloon mediated annihilation to prevent coronary obstruction with radiofrequency needle (LLAMACORN) for valve‐in‐valve transcatheter aortic valve replacement Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-03 Christina Mew, Arun Dahiya, Adrian A. Chong, Samual M. Hayman, Peter T. Moore, Danielle L. Harrop, Reza Reyaldeen, Christopher M. W. Cole, Jordan D. W. Ross, Shaun Roberts, Kellee A. Korver, Stephen V. Cox, Anthony C. Camuglia
Coronary obstruction (CO) is a potential pitfall for transcatheter aortic valve replacement (TAVR), especially in valve in valve procedures into degenerated surgical or transcatheter prostheses. Bioprosthetic leaflet modification techniques that incorporate electrosurgery are evolving as the preferred strategy to mitigate the risk of CO in high CO risk settings. The UNICORN method is proposed as a
-
Practices and outcomes of rotational atherectomy in China: The Rota China registry Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-03 Xiao Wang, Hong Zhang, Xiaojun Bai, Li Zhang, Chengxiang Li, Xiaobo Mao, Jue Chen, Jianfang Luo, Yan Zhao, Binquan Zhou, Bei'an You, Yuelan Zhang, Likun Ma, Zhimin Du, Yan Chen, Fucheng Sun, Chunguang Qiu, Zhujun Shen, Shangyu Wen, Gary S. Mintz, Fei Ye, Shaoping Nie
Rotational atherectomy (RA) remains an integral tool for the treatment of severe coronary calcified lesions despite emergence of newer techniques. We aimed to evaluate the contemporary clinical practices and outcomes of RA in China.
-
Kidney disease, diabetes, and diameter stenosis predict Rotablation bailout in modified balloon application for severely calcified coronary lesions Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-02 Dominik Felbel, Ali Fattom, Isabella Fechter, Michael Paukovitsch, Tilman Stephan, Matthias Gröger, Mirjam Keßler, Leonhard Schneider, Johannes Mörike, Birgid Gonska, Armin Imhof, Wolfgang Rottbauer, Dominik Buckert, Sinisa Markovic
Modified balloon (MB) treatment in severely calcified coronary artery lesions is an established technique. However, some lesions require Rotablation (RA) as bailout strategy.
-
Experience and perspective with intravascular imaging and invasive coronary physiology: Insights from allied health professionals Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-02 Waiel Abusnina, Ilan Merdler, Regina Deible, Bailey Estes, Bailey G. Salimes, Gary S. Mintz, Itsik Ben-Dor, Lowell F. Satler, Ron Waksman, Brian C. Case, Hayder D. Hashim
Although intravascular imaging (IVI) and invasive coronary physiology (ICP) are utilized in percutaneous coronary intervention (PCI) with robust positive clinical evidence, their adoption in cardiac catheterization laboratories (CCLs) is still limited.
-
Safety, feasibility, and incremental value of ultralow and zero contrast PCI in an all-comers registry Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-02 Abhishek C. Sawant, Nachiket Patel, Ashish Pershad
Patients with chronic kidney disease and CAD have been denied revascularization because of fear of precipitating acute renal failure from contrast exposure. Skepticism on whether Ultra-Low contrast percutaneous coronary intervention (PCI) or Zero contrast PCI (ULC/ZC PCI) can be safely performed has limited its adoption.
-
Diabetes and mortality risk in patients undergoing coronary angiography: The KARDIO study Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-02 Jari A. Laukkanen, Setor K. Kunutsor, Jaakko Immonen, Jussi Hernesniemi, Juha Karvanen, Markku Eskola
Diabetes is an established risk factor for adverse cardiovascular outcomes including mortality, but the relationship between diabetes and mortality risk in the presence of the extensive or diffuse form of coronary artery disease (CAD) is controversial.
-
The evolution of our understanding of mitral regurgitation Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-02 Blase Carabello
CONFLICT OF INTEREST STATEMENT The author declares no conflict of interest.
-
Cardiogenic shock severity predicts bleeding events in patients with temporary mechanical circulatory support Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-09-02 Kenjiro Oyabu, Hidetoshi Hattori, Noriko Kikuchi, Shintaro Haruki, Yuichiro Minami, Yuki Ichihara, Satoshi Saito, Shinichi Nunoda, Hiroshi Niinami, Junichi Yamaguchi
BackgroundData on shock severity and bleeding events in patients with temporary mechanical circulatory support (tMCS) are limited. We investigated the relationship between the Society for Cardiovascular Angiography and Interventions (SCAI) shock stage classification and bleeding events in patients with tMCS.MethodsWe evaluated the data of 285 consecutive patients with tMCS who were admitted to our
-
Intravascular lithotripsy in heavily calcified chronic total occlusion: procedural and one-year clinical outcomes Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-08-29 Federico Oliveri, Martijn J. H. van Oort, Ibtihal Al Amri, Brian O. Bingen, Bimmer E. Claessen, Aukelien C. Dimitriu-Leen, Joelle Kefer, Hany Girgis, Tessel Vossenberg, Frank van der, J. Wouter Jukema, Jose M. Montero-Cabezas
Calcification within chronic total occlusions (CTO) is strongly associated with worse outcomes. Despite the excellent success and safety of intravascular lithotripsy (IVL) in heavily calcified lesions, evidence in CTO remains scarce.
-
CT‐derived simulations to predict outcomes in patients undergoing transcatheter aortic valve implantation with an ACURATE Neo2 valve the PRECISE‐TAVI cohort B trial Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-08-28 Thijmen W. Hokken, Philippe Nuyens, Claudio Ruffo, Rutger‐Jan Nuis, Joost Daemen, Isabella Kardys, Ricardo Budde, Nicola Buzzatti, Ole de Backer, Nicolas M. Van Mieghem
BackgroundParavalvular leakage (PVL) and conduction disorders that require permanent pacemaker implantation (PPI) remain clinically relevant challenges after transcatheter aortic valve implantation (TAVI). Computed tomography‐based simulations may predict the risk of significant PVL and PPI.AimsTo evaluate the feasibility and accuracy of preprocedural computer simulation with FEops HEARTguide™ to predict
-
Outcomes among patients with non‐ST‐elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-08-27 Ahmed M. Younes, Ahmed Hashem, Ahmed Maraey, Mahmoud Khalil, Ahmed Elzanaty, Islam Y. Elgendy
BackgroundChronic systemic anticoagulation use is prevalent for various thromboembolic conditions. Anticoagulation (usually through heparin products) is also recommended for the initial management of non‐ST‐elevation myocardial infarction (NSTEMI).AimsTo evaluate the in‐hospital outcomes of patients with NSTEMI who have been on chronic anticoagulation.MethodsUsing the National Inpatient Sample (NIS)
-
Outcomes of revascularization of stenotic inframalleolar lesions in chronic limb-threatening ischemia Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-08-27 Riho Suzuki, Yutaka Dannoura, Takao Makino, Hisashi Yokoshiki
For chronic limb-threatening ischemia, revascularization has been reported for occlusions but not for stenosis in the inframalleolar (IM) lesions. We investigated the clinical outcomes of balloon dilation for stenotic IM lesions distal to the treatment target in the infrapopliteal (IP) legion.
-
Prevention and treatment of coronary catheter kinking Catheter. Cardiovasc. Interv. (IF 2.1) Pub Date : 2024-08-27 Mahmoud M. Elrayes, Ahmed Al-Ogaili, Sandeep Jalli, Emmanouil S. Brilakis
Coronary catheter kinking is an uncommon but potentially catastrophic complication of cardiac catheterization. Although simple maneuvers can often result in resolution of a kink, tighter knots may not respond to such measures. We provide a systematic, stepwise approach to the prevention and treatment of catheter kinking.